Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Bone ; 46(5): 1424-35, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20152952

RESUMO

Recently, our group has proposed a combinatorial strategy in tissue engineering principles employing carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles (CMCht/PAMAM) towards the intracellular release and regimented supply of dexamethasone (Dex) aimed at controlling stem cell osteogenic differentiation in the absence of typical osteogenic inducers, in vivo. In this work, we have investigated if the Dex-loaded CMCht/PAMAM dendrimer nanoparticles could play a crucial role in the regulation of osteogenesis, in vivo. Macroporous hydroxyapatite (HA) scaffolds were seeded with rat bone marrow stromal cells (RBMSCs), whose cells were expanded in MEM medium supplemented with 0.01 mg ml(-1) Dex-loaded CMCht/PAMAM dendrimer nanoparticles and implanted subcutaneously on the back of rats for 2 and 4 weeks. HA porous ceramics without RBMSCs and RBMSCs/HA scaffold constructs seeded with cells expanded in the presence and absence of 10(-8) M Dex were used as controls. The effect of initial cell number seeded in the HA scaffolds on the bone-forming ability of the constructs was also investigated. Qualitative and quantitative new bone formation was evaluated in a non-destructive manner using micro-computed tomography analyses of the explants. Haematoxylin and Eosin stained implant sections were also used for the histomorphometrical analysis. Toluidine blue staining was carried out to investigate the synthesis of proteoglycan extracellular matrix. In addition, alkaline phosphatase and osteocalcin levels in the explants were also quantified, since these markers denote osteogenic differentiation. At 4 weeks post-implantation results have shown that the novel Dex-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles may be beneficial as an intracellular nanocarrier, supplying Dex in a regimented manner and promoting superior ectopic de novo bone formation.


Assuntos
Quitosana/química , Dendrímeros/química , Dexametasona/química , Nanopartículas/química , Células Estromais/citologia , Engenharia Tecidual , Alicerces Teciduais/química , Fosfatase Alcalina/metabolismo , Animais , Células Cultivadas , Durapatita/química , Masculino , Microscopia , Osteocalcina/metabolismo , Osteogênese/fisiologia , Ratos , Ratos Endogâmicos F344 , Células Estromais/metabolismo , Microtomografia por Raio-X
2.
Gene Ther ; 17(4): 494-502, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19940865

RESUMO

Mesenchymal stem cells (MSCs) can differentiate into multiple cell lineages and are used for regenerative treatments for a variety of diseases. However, the patient's cells cannot be used to treat genetic diseases. Allogeneic cells can serve as an alternative but long-term survival is uncertain. Our experience of allo-transplantation to a patient with hypophosphatasia, which is caused by mutations of the tissue non-specific alkaline phosphatase (TNSALP) gene resulting in low serum alkaline phosphatase (ALP) activity and skeletal deformity, did not improve these clinical characteristics. Therefore, we sought to use autologous MSCs for the treatment of hypophosphatasia. MSCs derived from the patient's bone marrow had a similar profile when compared with well-reported MSCs. However, the MSCs had extremely low ALP activity and could not produce a mineralized bone matrix even under the osteogenic culture conditions. We therefore transduced a retroviral vector with TNSALP promoter-driven TNSALP gene in the MSCs. In the culture condition, the MSCs had about 7-fold higher ALP activity than did mock-transduced MSCs, and showed mineralization as well as bone-specific markers. Furthermore, the MSCs, but not mock-transduced MSCs, newly formed bone at the frequency of 50% in nude rats. Transplantation of the TNSALP-transduced autologous MSCs might become a new therapy for hypophosphatasia.


Assuntos
Fosfatase Alcalina/metabolismo , Hipofosfatasia/genética , Hipofosfatasia/terapia , Células-Tronco Mesenquimais/metabolismo , Osteogênese/fisiologia , Transplante de Células-Tronco/métodos , Fosfatase Alcalina/sangue , Fosfatase Alcalina/genética , Animais , Sequência de Bases , Diferenciação Celular/fisiologia , Primers do DNA/genética , Feminino , Citometria de Fluxo , Vetores Genéticos/genética , Humanos , Lactente , Dados de Sequência Molecular , Osteogênese/genética , Ratos , Ratos Nus , Retroviridae , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNA , Transdução Genética
3.
Calcif Tissue Int ; 73(6): 575-83, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12958691

RESUMO

An osteoblastic cell line (HOS cells) produces a prominent osteoid matrix with mineralization. Fibroblasts, on the other hand, do not exhibit this mineralization. To evaluate the degree of mineralization, we added calcein to the culture medium and then observed the culture wells by using an image analyzer. The calcein uptake into the cell/matrix layer was detected in the HOS cells but not in the fibroblasts. The calcein uptake was also quantified in situ by using an image analyzer, which revealed high levels in the HOS cells, which correlated well with the calcium content of the mineralized matrix. Rat marrow cells were also cultured in media containing calcein, fetal bovine serum, beta-glycerophosphate, L-ascorbic acid 2-phosphate, and with or without dexamethasone. With the dexamethasone, the cells exhibited osteogenic differentiation that resulted in mineralized matrix formation after about 10 days. The matrix formation coincided with the appearance of calcein uptake into the cell/matrix layer, with the amount of calcein uptake increasing with time. By contrast, the culture without the dexamethasone did not exhibit matrix formation and the calcein uptake was negligible. In the case of both HOS cell and rat marrow cell cultures in vitro, calcein did not affect expressions of their alkaline phosphatase activity or osteocalcin production. Furthermore, histologic observation revealed that rat marrow cells subcultured with calcein could show osteogenic ability after in vivo implantation. These results suggest that the current method of detecting calcein uptake in a culture allows the monitoring of the osteogenic capacity of cultured cells, as well as the measurement of the amount of mineralization produced by the osteogenic cells. Given that osteogenic cultured cells/mineralized matrices are used in bone reconstruction surgery, the in situ monitoring method is invaluable in that it allows us to evaluate the osteogenic capacity of in vitro constructs.


Assuntos
Calcificação Fisiológica/fisiologia , Osteoblastos/metabolismo , Fosfatase Alcalina/metabolismo , Animais , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/enzimologia , Transplante de Medula Óssea , Calcificação Fisiológica/efeitos dos fármacos , Linhagem Celular Tumoral , Transplante de Células , Dexametasona/farmacologia , Combinação de Medicamentos , Ensaio de Imunoadsorção Enzimática , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Fluoresceínas/farmacologia , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Microscopia de Fluorescência , Osteoblastos/efeitos dos fármacos , Ratos , Ratos Endogâmicos F344
4.
Hum Mol Genet ; 9(14): 2075-83, 2000 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10958646

RESUMO

Human chromosome 11p15.5 harbors an intriguing imprinted gene cluster of 1 Mb. This imprinted domain is implicated in a wide variety of malignancies and Beckwith-Wiedemann syndrome (BWS). Recently, several lines of evidence have suggested that the BWS-associated imprinting cluster consists of separate chromosomal domains. We have previously identified LIT1, a paternally expressed antisense RNA within the KvLQT1 locus through a positional screening approach using human monochromosomal hybrids. KvLQT1 encompasses the translocation breakpoint cluster in BWS and patients exhibit frequent loss of maternal methylation at the LIT1 CpG island, implying a regulatory role for the LIT1 locus in coordinate control of the imprinting cluster. Here we generated modified human chromosomes carrying a targeted deletion of the LIT1 CpG island using recombination-proficient chicken DT40 cells. Consistent with the prediction, this mutation abolished LIT1 expression on the paternal chromosome, accompanied by activation of the normally silent paternal alleles of multiple imprinted loci at the centromeric domain including KvLQT1 and p57(KIP2). The deletion had no effect on imprinting of H19 located at the telomeric end of the cluster. Our findings demonstrate that the LIT1 CpG island can act as a negative regulator in cis for coordinate imprinting at the centromeric domain, thereby suggesting a role for the LIT1 locus in a BWS pathway leading to functional inactivation of p57(KIP2). Thus, the targeting and precise modification of human chromosomal alleles using the DT40 cell shuttle system can be used to define regulatory elements that confer long-range control of gene activity within chromosomal domains.


Assuntos
Síndrome de Beckwith-Wiedemann/genética , Regulação da Expressão Gênica , Impressão Genômica , Mutagênese Sítio-Dirigida , Alelos , Animais , Southern Blotting , Células CHO , Linhagem Celular , Centrômero , Galinhas , Cromossomos/metabolismo , Cromossomos Humanos Par 11 , Ilhas de CpG , Cricetinae , Metilação de DNA , Pai , Humanos , Células Híbridas , Hibridização in Situ Fluorescente , Modelos Genéticos , Mães , Família Multigênica , Mapeamento Físico do Cromossomo , RNA/metabolismo , RNA Antissenso/metabolismo , Recombinação Genética , Translocação Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA